Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Cash Flows from Operating Activities
Net earnings	$ 61,275	$ 83,018	$ 38,735
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	30,242	25,669	19,127
Amortization	4,451	2,777	1,912
Share-based compensation expense	11,584	9,972	8,790
(Gain) Loss on foreign currency transactions	(1,514)	(405)	2,951
Gain on sale of equity investment	(1,021)	(168)
Earnings from equity investments	(1,059)	(579)	(375)
Deferred income taxes	577	(2,068)	(951)
Excess tax benefits from share-based compensation expense	(821)	(4,053)	(976)
Increase (decrease) in cash from changes in:
Accounts receivable	(8,931)	(7,197)	(23,447)
Inventories	(8,988)	(40,403)	2,657
Accounts payable	2,898	2,647	6,488
Income taxes payable	2,824	(2,722)	6,459
Other operating net assets	(3,448)	7,006	11,050
Net cash provided by operating activities	88,069	73,494	72,420
Cash Flows from Investing Activities
Additions to property, plant and equipment	(42,840)	(40,859)	(13,837)
Purchase of businesses, net of cash acquired	(46,141)	(12,813)	(45,600)
Proceeds from sale of equity method investment	3,478
Investments in unconsolidated businesses		(1,180)	(4,814)
Proceeds from collection of notes receivable		2,000
Other investing activities	615	360	(811)
Net cash used in investing activities	(84,888)	(52,492)	(65,062)
Cash Flows from Financing Activities
Proceeds on long-term borrowings	7,000	15,000
Payments on long-term borrowings	(14,295)		(558)
Proceeds from exercises of stock options	2,658	6,206	2,611
Excess tax benefits from share-based compensation expense	821	4,053	976
Payments on cash earnout arrangement	(6,000)	(6,000)
Purchases of treasury stock	(4,988)
Payments of deferred financing costs		(105)
Net cash (used in) provided by financing activities	(14,804)	19,154	3,029
Effect of exchange rate changes on cash and cash equivalents	(2,893)	1,278	1,709
Net (decrease) increase in cash and cash equivalents	(14,516)	41,434	12,096
Cash and Cash Equivalents at Beginning of Period	149,460	108,026	95,930
Cash and Cash Equivalents at End of Period	134,944	149,460	108,026
Non-cash transactions:
Note receivable received from the sale of an equity investment	2,022
Purchase of business by issuing Common Stock of the Company			36,851
Purchases of business utilizing earnout consideration recorded in current and long-term liabilities			$ 11,900